Detalles de la búsqueda
1.
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Blood
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588489
2.
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
Br J Cancer
; 126(3): 482-491, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34471258
3.
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
Br J Cancer
; 127(5): 908-915, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650277
4.
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia.
Haematologica
; 107(3): 635-643, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567813
5.
Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.
Pediatr Blood Cancer
; 69(1): e29361, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597466
6.
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
Br J Cancer
; 125(1): 55-64, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837299
7.
CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 193(1): 171-175, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620089
8.
Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?
Pediatr Blood Cancer
; 68(4): e28945, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33565233
9.
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab.
Pediatr Blood Cancer
; 68(5): e28922, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33638292
10.
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.
Int J Cancer
; 146(7): 1902-1916, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325323
11.
Addition of Thiotepa to Total Body Irradiation and Cyclophosphamide Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(11): 2068-2074, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32736010
12.
Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
Br J Cancer
; 123(5): 742-751, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536690
13.
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.
Haematologica
; 105(7): 1887-1894, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601692
14.
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(4): e28133, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31876116
15.
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology.
Blood
; 129(20): 2771-2781, 2017 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28331056
16.
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
Br J Cancer
; 118(7): 1000-1004, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531323
17.
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Br J Haematol
; 180(4): 550-562, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29194562
18.
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Blood
; 128(7): 911-22, 2016 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27229005
19.
Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features.
Br J Haematol
; 196(6): 1407-1411, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897646
20.
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia.
Blood
; 126(10): 1193-202, 2015 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26116659